Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18707823rdf:typepubmed:Citationlld:pubmed
pubmed-article:18707823lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:18707823lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:18707823lifeskim:mentionsumls-concept:C0007137lld:lifeskim
pubmed-article:18707823lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:18707823lifeskim:mentionsumls-concept:C0521115lld:lifeskim
pubmed-article:18707823pubmed:issue4lld:pubmed
pubmed-article:18707823pubmed:dateCreated2009-3-2lld:pubmed
pubmed-article:18707823pubmed:abstractTextTo evaluate the feasibility and efficacy of a hyperfractionated accelerated radiotherapy (RT) schedule combined with concomitant chemotherapy (Cx) in patients with locally advanced head-and-neck squamous cell carcinoma.lld:pubmed
pubmed-article:18707823pubmed:languageenglld:pubmed
pubmed-article:18707823pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18707823pubmed:citationSubsetIMlld:pubmed
pubmed-article:18707823pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18707823pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18707823pubmed:statusMEDLINElld:pubmed
pubmed-article:18707823pubmed:monthMarlld:pubmed
pubmed-article:18707823pubmed:issn1879-355Xlld:pubmed
pubmed-article:18707823pubmed:authorpubmed-author:Van den...lld:pubmed
pubmed-article:18707823pubmed:authorpubmed-author:DelaerePierre...lld:pubmed
pubmed-article:18707823pubmed:authorpubmed-author:HermansRobert...lld:pubmed
pubmed-article:18707823pubmed:authorpubmed-author:ClementPaul...lld:pubmed
pubmed-article:18707823pubmed:authorpubmed-author:SchoenaersJos...lld:pubmed
pubmed-article:18707823pubmed:authorpubmed-author:NuytsSandraSlld:pubmed
pubmed-article:18707823pubmed:authorpubmed-author:DirixPietPlld:pubmed
pubmed-article:18707823pubmed:authorpubmed-author:PoortenVincen...lld:pubmed
pubmed-article:18707823pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18707823pubmed:day15lld:pubmed
pubmed-article:18707823pubmed:volume73lld:pubmed
pubmed-article:18707823pubmed:ownerNLMlld:pubmed
pubmed-article:18707823pubmed:authorsCompleteYlld:pubmed
pubmed-article:18707823pubmed:pagination1088-95lld:pubmed
pubmed-article:18707823pubmed:meshHeadingpubmed-meshheading:18707823...lld:pubmed
pubmed-article:18707823pubmed:meshHeadingpubmed-meshheading:18707823...lld:pubmed
pubmed-article:18707823pubmed:meshHeadingpubmed-meshheading:18707823...lld:pubmed
pubmed-article:18707823pubmed:meshHeadingpubmed-meshheading:18707823...lld:pubmed
pubmed-article:18707823pubmed:meshHeadingpubmed-meshheading:18707823...lld:pubmed
pubmed-article:18707823pubmed:meshHeadingpubmed-meshheading:18707823...lld:pubmed
pubmed-article:18707823pubmed:meshHeadingpubmed-meshheading:18707823...lld:pubmed
pubmed-article:18707823pubmed:meshHeadingpubmed-meshheading:18707823...lld:pubmed
pubmed-article:18707823pubmed:meshHeadingpubmed-meshheading:18707823...lld:pubmed
pubmed-article:18707823pubmed:meshHeadingpubmed-meshheading:18707823...lld:pubmed
pubmed-article:18707823pubmed:meshHeadingpubmed-meshheading:18707823...lld:pubmed
pubmed-article:18707823pubmed:meshHeadingpubmed-meshheading:18707823...lld:pubmed
pubmed-article:18707823pubmed:meshHeadingpubmed-meshheading:18707823...lld:pubmed
pubmed-article:18707823pubmed:year2009lld:pubmed
pubmed-article:18707823pubmed:articleTitleImpact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.lld:pubmed
pubmed-article:18707823pubmed:affiliationDepartment of Radiation Oncology, Leuvens Kankerinstituut, University Hospitals Leuven, campus Gasthuisberg, Leuven, Belgium. sandra.nuyts@uzleuven.belld:pubmed
pubmed-article:18707823pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18707823pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed